ALS diagnostic criteria of El Escorial Revisited: do they meet the needs of clinicians as well as researchers?

  title={ALS diagnostic criteria of El Escorial Revisited: do they meet the needs of clinicians as well as researchers?},
  author={Jerry M. Belsh},
  journal={Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders},
  pages={S57 - S60}
  • J. Belsh
  • Published 1 March 2000
  • Medicine
  • Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
The El Escorial criteria for diagnosis of amyotrophic lateral sclerosis (ALS) have been in use for almost a decade. A revised set of criteria, meant to supersede the original set, was developed at a 1998 World Federation of Neurology (WFN) ALS meeting at Airlie House in Warrenton, Virginia, USA. This revised document, nicknamed El Escorial Revisited, has been published on the WFN-ALS website. El Escorial has proven useful in standardizing diagnostic criteria for entry into research trials and… 
The revised El Escorial criteria “clinically probable laboratory supported ALS”—once a promising now a superfluous category?
In the PRO-ACT dataset, progression in ALS patients included at baseline into the “clinically probable laboratory supported” category was significantly slower compared to the other EEC categories and exhibited a significantly longer diagnostic delay, suggesting that the bias toward slow progressors in this category is an inherent problem of the category.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Our objective was to explore the efficacy and safety of edaravone in amyotrophic lateral sclerosis (ALS) patients with a Japan ALS severity classification of Grade 3. In a 24-week, double-blind,
A clinical epidemiological study of 251 cases of amyotrophic lateral sclerosis in the south of Brazil.
Domestic work and heavy occupations appear to be related to precocious perception of the symptoms by interference with daily functions in patients with clinical forms of amyotrophic lateral sclerosis in Paraná, Brazil.
Chapter 16 Primary lateral sclerosis.
  • A. Eisen
  • Medicine
    Handbook of clinical neurology
  • 2007
A multimodal approach as has been successfully applied in ALS and multiple sclerosis could prove effective in PLS, and the abnormalities seen occur equally in classic ALS.
Amyotrophic lateral sclerosis: Analysis of ALS cases in a predominantly admixed population of Ecuador
Investigation in the predominantly admixed population of Ecuador found that ALS incidence in the Ecuadorian hospital population is in accord with rates reported in recent studies for other admixed populations, and lower than that in the United States and Europe.
Chapter 1 Clinical Principles in the Diagnosis of Motor Neuron Disorders
This chapter discusses the clinical approach to the diagnosis of motor neuron disorders, which includes neuroimaging, a number of biochemical and hematological tests, and an electromyography (EMG) to ascertain the extent of lower motor neuron (LMN) involvement.
Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis
It is confirmed that diagnosis of ALS is still a common clinical problem and shows the need of sensitive and specific diagnostic tests.
Amyotrophic Lateral Sclerosis Mortality in the United States, 1979–2001
A retrospective analysis of ALS-associated death rates and trends in the United States for 1979–2001 using death records from the national multiple cause-of-death database suggests small increases in the overall age-adjusted death rate and in the death rates among elderly women and adults 20–49 years of age.
Riluzole therapy for motor neurone disease: An early Australian experience (1996–2002)
Long-term survival data for patients in the present series suggest a greater benefit for patients who commenced riluzole early in the course of their illness, and issues related to patient perceptions of efficacy highlight the need for patients and treating physicians to maintain realistic expectations of rILuzole therapy.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Our objective was to identify whether rare genetic variation in amyotrophic lateral sclerosis (ALS) candidate survival genes modifies ALS survival. Candidate genes were selected based on evidence for


Toward earlier diagnosis of amyotrophic lateral sclerosis
The World Federation of Neurology diagnostic criteria for ALS was modified and used for enrollment of ALS patients in a clinical trial and the diagnosis of ALS was believed to be accurate in those patients entered in the trial.
ALS Diagnostic criteria, El Escorial, and Philip II of Spain: A historical perspective
  • J. Belsh
  • Psychology, Medicine
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases
  • 1999
El Escorial, a magnificent palace-monastery in central Spain, was the setting in 1990 for a meeting of ALS experts who developed a consensus document called the El Escorial ALS Diagnostic Criteria.
Amyotrophic lateral sclerosis : diagnosis and management for the clinician
Part 1: DIAGNOSIS 1. Epidemiology and Historical Perspective of ALS 2. Etiology and Pathogenesis of ALS: Biochemical, Genetic, and Other Theories 3. Definition of Terms, Classification, and
Consensus guidelines for the design and implementation of clinical trials in ALS
Expanded areas of focus include greater protection of patient rights, more detailed guidelines for outcome measures statistical analyses, disclosure of study results and improved interaction between investigators and the corporate sector.
Misdiagnosis in patients with amyotrophic lateral sclerosis.
Most likely causes of misdiagnosis were physicians' failure to consider the diagnosis and lack of familiarity with the common clinical presentations of amyotrophic lateral sclerosis.
Differential diagnosis of ALS: Part I. Non-motor neuron diseases and adult-onset spinal muscular atrophies
  • Armonk, NY: Futura,
  • 1996
Misdiagnosis in ALS: therapeutic and psychological implications
  • Presented at 5 International Symposium on ALS/MND, Noordwijk, Holland,
  • 1994